{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:13:04Z","timestamp":1786374784730,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.2459\/jcm.0b013e32833e58e4","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T08:56:31Z","timestamp":1283331391000},"page":"102-109","source":"Crossref","is-referenced-by-count":4,"title":["Long-term outcomes with cobalt-chromium bare-metal vs. drug-eluting stents: the REgistro regionale AngiopLastiche dell'Emilia-Romagna registry"],"prefix":"10.2459","volume":"12","author":[{"given":"Antonio","family":"Manari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ortolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Guastaroba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Marzaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Menozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Magnavacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Varani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Vignali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Marzocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210207","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"R2-6-20210207","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa066633","article-title":"A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Spaulding","year":"2007","journal-title":"N Engl J Med"},{"key":"R3-6-20210207","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","article-title":"Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden","volume":"356","author":"Lagerqvist","year":"2007","journal-title":"N Engl J Med"},{"key":"R4-6-20210207","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1161\/CIRCULATIONAHA.106.667592","article-title":"Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry","volume":"115","author":"Marzocchi","year":"2007","journal-title":"Circulation"},{"key":"R5-6-20210207","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.amjcard.2008.08.068","article-title":"Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients","volume":"103","author":"Kukreja","year":"2009","journal-title":"Am J Cardiol"},{"key":"R6-6-20210207","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents","volume":"48","author":"Pfisterer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R7-6-20210207","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","article-title":"Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern","volume":"115","author":"Camenzind","year":"2007","journal-title":"Circulation"},{"key":"R8-6-20210207","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.amjmed.2006.01.023","article-title":"Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials","volume":"119","author":"Bavry","year":"2006","journal-title":"Am J Med"},{"key":"R9-6-20210207","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1161\/01.CIR.103.23.2816","article-title":"Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial","volume":"103","author":"Kastrati","year":"2001","journal-title":"Circulation"},{"key":"R10-6-20210207","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9149(03)00669-6","article-title":"Usefulness of a cobalt chromium coronary stent alloy","volume":"92","author":"Kereiakes","year":"2003","journal-title":"Am J Cardiol"},{"key":"R11-6-20210207","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2004.08.055","article-title":"Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system","volume":"95","author":"Sketch","year":"2005","journal-title":"Am J Cardiol"},{"key":"R12-6-20210207","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ccd.21011","article-title":"Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization","volume":"69","author":"Ortolani","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"R13-6-20210207","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2005.01.096","article-title":"Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events","volume":"95","author":"Marzocchi","year":"2005","journal-title":"Am J Cardiol"},{"key":"R14-6-20210207","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"key":"R15-6-20210207","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"Mauri","year":"2007","journal-title":"N Engl J Med"},{"key":"R16-6-20210207","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/euhj.2000.2305","article-title":"Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction.","volume":"21","year":"2000","journal-title":"Eur Heart J"},{"key":"R17-6-20210207","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"key":"R18-6-20210207","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0895-4356(93)90103-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives","volume":"46","author":"Romano","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"R19-6-20210207","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.CIR.103.2.192","article-title":"Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study","volume":"103","author":"Sousa","year":"2001","journal-title":"Circulation"},{"key":"R20-6-20210207","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.105.591206","article-title":"Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial","volume":"114","author":"Fajadet","year":"2006","journal-title":"Circulation"},{"key":"R21-6-20210207","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/01.CIR.0000112572.57794.22","article-title":"Analysis of 1-year clinical outcomes in the SIRIUS trial. A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis","volume":"109","author":"Holmes","year":"2004","journal-title":"Circulation"},{"key":"R22-6-20210207","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa071076","article-title":"Effectiveness and safety of drug-eluting stents in Ontario","volume":"357","author":"Tu","year":"2007","journal-title":"N Engl J Med"},{"key":"R23-6-20210207","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa0706258","article-title":"A comparison of bare-metal and drug-eluting stents for off-label indications","volume":"358","author":"Marroquin","year":"2008","journal-title":"N Engl J Med"},{"key":"R24-6-20210207","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.amjcard.2007.08.048","article-title":"Impact of \u2018off-label\u2019 utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention","volume":"101","author":"Roy","year":"2008","journal-title":"Am J Cardiol"},{"key":"R25-6-20210207","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2007.08.064","article-title":"Off-label' stent therapy 2-year comparison of drug-eluting versus bare-metal stents","volume":"51","author":"Applegate","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R26-6-20210207","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/eurheartj\/ehn516","article-title":"Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET","volume":"30","author":"Pfisterer","year":"2009","journal-title":"Eur Heart J"},{"key":"R27-6-20210207","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Kastrati","year":"2007","journal-title":"N Engl J Med"},{"key":"R28-6-20210207","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1001\/jama.299.24.2868","article-title":"Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents","volume":"299","author":"Malenka","year":"2008","journal-title":"JAMA"},{"key":"R29-6-20210207","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIRCULATIONAHA.107.725531","article-title":"Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents","volume":"117","author":"Hannan","year":"2008","journal-title":"Circulation"},{"key":"R30-6-20210207","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4244\/EIJV5I1A10","article-title":"Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry","volume":"5","author":"Saia","year":"2009","journal-title":"EuroIntervention"},{"key":"R31-6-20210207","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(05)67221-2","article-title":"Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET)","volume":"366","author":"Kaiser","year":"2005","journal-title":"Lancet"},{"key":"R32-6-20210207","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1161\/01.CIR.0000079018.84618.0E","article-title":"Drug-eluting stents: costs versus clinical benefit","volume":"107","author":"O'Neill","year":"2003","journal-title":"Circulation"}],"container-title":["Journal of Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01244665-201102000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:16:37Z","timestamp":1786371397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01244665-201102000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2459\/jcm.0b013e32833e58e4","relation":{},"ISSN":["1558-2027"],"issn-type":[{"value":"1558-2027","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}